Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy

por Hentzen, Stijn, Mehta, Kathan, Al-Rajabi, Raed Moh’d Taiseer, Saeed, Anwaar, Baranda, Joaquina Celebre, Williamson, Stephen K., Sun, Weijing, Kasi, Anup
Publicado 2023

Leiomyosarcoma of the inferior vena cava: a case report and review of the literature

por Reddy, Venkataprasanth P, VanVeldhuizen, Peter J, Muehlebach, Gregory F, Dusing, Reginald W, Birkbeck, James P, Williamson, Stephen K, Krishnan, Leela, Meyers, David G
Publicado 2010

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors

por Richardson, Gary Edward, Al-Rajabi, Raed, Uprety, Dipesh, Hamid, Anis, Williamson, Stephen K., Baranda, Joaquina, Mamdani, Hirva, Lee, Ya-Li, Nitika, Li, Li, Wang, Xingli, Dong, Xunwei
Publicado 2023

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

por Huang, Chao H., Williamson, Stephen K., Neupane, Prakash, Taylor, Sarah A., Allen, Ace, Smart, Nora J., Uypeckcuat, Adelina M., Spencer, Sarah, Wick, Jo, Smith, Holly, Van Veldhuizen, Peter J., Kelly, Karen
Publicado 2016

A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

por Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Publicado 2014

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

por McGarrah, Patrick, Hubbard, Joleen, Novotny, Paul J., Branda, Megan E., Sargent, Daniel S., Morton, Roscoe F., Fuchs, Charles S., Benson, Al B., Williamson, Stephen K., Findlay, Brian P., Alberts, Steven R., Goldberg, Richard M., Sloan, Jeff A.
Publicado 2023

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

por Mar, Nataliya, Zakharia, Yousef, Falcon, Alejandro, Morales-Barrera, Rafael, Mellado, Begona, Duran, Ignacio, Oh, Do-Youn, Williamson, Stephen K., Gajate, Pablo, Arkenau, Hendrik-Tobias, Jones, Robert J., Teo, Min Yuen, Turan, Tolga, McLaughlin, Robert T., Peltier, Hillary M., Chong, Elizabeth, Atluri, Harisha, Dean, James P., Castellano, Daniel
Publicado 2023

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

por Oh, Do-Youn, Maqueda, Maria Alsina, Quinn, David I., O’Dwyer, Peter J., Chau, Ian, Kim, Sun Young, Duran, Ignacio, Castellano, Daniel, Berlin, Jordan, Mellado, Begona, Williamson, Stephen K., Lee, Keun-Wook, Marti, Francisca, Mathew, Paul, Saif, Muhammad Wasif, Wang, Ding, Chong, Elizabeth, Hilger-Rolfe, Jacqueline, Dean, James P., Arkenau, Hendrik-Tobias
Publicado 2023